Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial-Reference-Cited by-同舟云学术

Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial

Published:2017-07 Issue:7 Volume:7 Page:e014546
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Flicoteaux Remi,Protopopescu Camelia,Tibi Annick,Blanchon Thierry,Werf Sylvie Van Der,Duval Xavier,Mosnier Anne,Charlois-Ou Cécile,Lina Bruno,Leport Catherine,Chevret Sylvie

Funder

French Ministry of Health

Publisher

BMJ

Subject

General Medicine

Reference27 articles.

1. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children;Jefferson;Cochrane Database Syst Rev,2014

2. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial;Duval;PLoS Med,2010

3. A new taxonomy for describing and defining adherence to medications;Vrijens;Br J Clin Pharmacol,2012

4. WHO. Adherence to Long-term therapies: evidence for action. 2003 http://www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed on Jun 2016).

5. ‘nonadherence’: a bitter pill for drug trials;Biomedicine;Science,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on experimental studies about patient adherence to treatment;Pharmacology Research & Perspectives;2024-01-11

2. Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan;Infectious Diseases and Therapy;2024-01

3. Influenza Management During the COVID-19 Pandemic: A Review of Recent Innovations in Antiviral Therapy and Relevance to Primary Care Practice;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2021-12

4. Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol;BMC Infectious Diseases;2021-08-09

5. Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis;Journal of Medical Economics;2021-01-01